Fresenius Medical Care AG Depreciation & Amortization Growth & History (FME)
Fresenius Medical Care AG's depreciation and amortization was €1.46B for fiscal 2025.
View full Fresenius Medical Care AG company overviewFresenius Medical Care AG annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.46B | −€72.1M | −4.70% |
| 2024 | 2024-12-31 | €1.54B | −€77.2M | −4.79% |
| 2023 | 2023-12-31 | €1.61B | −€106.1M | −6.17% |
| 2022 | 2022-12-31 | €1.72B | €133.4M | +8.42% |
| 2021 | 2021-12-31 | €1.59B | −€1.5M | −0.09% |
| 2020 | 2020-12-31 | €1.59B | €33.5M | +2.15% |
| 2019 | 2019-12-31 | €1.55B | €828.6M | +114.31% |
| 2018 | 2018-12-31 | €724.8M | −€10.6M | −1.45% |
| 2017 | 2017-12-31 | €735.5M | €33.9M | +4.84% |
| 2016 | 2016-12-31 | €701.5M | €53.4M | +8.23% |
| 2015 | 2015-12-31 | €648.2M | — | — |
Fresenius Medical Care AG quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €363.1M | €1.1M | +0.30% |
| Q1 2026 | 2026-03-31 | €462.9M | €80.3M | +21.00% |
| Q4 2025 | 2025-12-31 | €373.6M | — | — |
| Q3 2025 | 2025-09-30 | €358.2M | −€13.9M | −3.73% |
| Q2 2025 · Jun 30 | 2025-06-30 | €362.0M | −€21.7M | −5.66% |
| Q1 2025 | 2025-03-31 | €382.6M | −€5.1M | −1.33% |
| Q3 2024 | 2024-09-30 | €372.1M | −€20.5M | −5.23% |
| Q2 2024 · Jun 30 | 2024-06-30 | €383.8M | −€22.3M | −5.49% |
| Q1 2024 | 2024-03-31 | €387.7M | −€23.9M | −5.80% |
| Q3 2023 | 2023-09-30 | €392.6M | −€50.0M | −11.30% |
| Q2 2023 · Jun 30 | 2023-06-30 | €406.1M | −€16.0M | −3.78% |
| Q1 2023 | 2023-03-31 | €411.6M | −€2.6M | −0.62% |
| Q3 2022 | 2022-09-30 | €442.6M | €46.2M | +11.67% |
| Q2 2022 · Jun 30 | 2022-06-30 | €422.0M | €35.2M | +9.09% |
| Q1 2022 | 2022-03-31 | €414.2M | €26.3M | +6.77% |
| Q3 2021 | 2021-09-30 | €396.4M | €225,000 | +0.06% |
| Q2 2021 · Jun 30 | 2021-06-30 | €386.9M | −€18.0M | −4.45% |
| Q1 2021 | 2021-03-31 | €387.9M | −€11.8M | −2.94% |
| Q3 2020 · Sep 30 | 2020-09-30 | €396.2M | −€13.1M | −3.20% |
| Q2 2020 | 2020-06-30 | €404.9M | €17.9M | +4.62% |
| Q1 2020 | 2020-03-31 | €399.7M | €37.3M | +10.29% |
| Q3 2019 | 2019-09-30 | €409.3M | €230.5M | +128.93% |
| Q2 2019 · Jun 30 | 2019-06-30 | €387.0M | €206.8M | +114.71% |
| Q1 2019 | 2019-03-31 | €362.4M | €187.4M | +107.08% |
| Q3 2018 | 2018-09-30 | €178.8M | €998,000 | +0.56% |
| Q2 2018 · Jun 30 | 2018-06-30 | €180.2M | −€5.8M | −3.13% |
| Q1 2018 | 2018-03-31 | €175.0M | −€14.9M | −7.85% |
| Q3 2017 | 2017-09-30 | €177.8M | — | — |
| Q2 2017 · Jun 30 | 2017-06-30 | €186.1M | — | — |
| Q1 2017 | 2017-03-31 | €189.9M | — | — |
Fresenius Medical Care AG depreciation and amortization trends
Over the last five fiscal years, Fresenius Medical Care AG's depreciation and amortization decreased from €1.59B to €1.46B, a change of −€123.5M. The latest reported quarter, Q2 2026, shows €363.1M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fresenius Medical Care AG source filings ↗